Aclaris Therapeutics: HC Wainwright Raises Buy Rating to $16.

jueves, 19 de marzo de 2026, 8:17 am ET1 min de lectura
ACRS--

Aclaris Therapeutics: HC Wainwright Raises Buy Rating to $16.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios